Sharp Edge Labs
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2403 Sidney St Ste 263, Pittsburgh, Penn...Phone Number
(978) 239-6749Website
www.sharptx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Sharp Edge Labs
Sharp Therapeutics is focused on developing first-choice medicines for hereditary disorders by utilizing high-speed experimentation and modern computational methods. Their innovative Disco platform enables the rapid discovery of small molecules aimed at correcting protein defects in conditions such as Gaucher Disease, Familial Frontotemporal Dementia, and Niemann Pick Type-C. The company aims to streamline the drug development process, making it faster and more cost-effective, ultimately providing patients with clear oral treatment options. Targeting patients, healthcare providers, and the healthcare system, Sharp Therapeutics is committed to delivering effective therapies for genetic diseases.Explore more
Sharp Edge Labs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sharp Edge Labs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Sharp Edge Labs had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sharp Edge Labs
Earning: See what the market has to say on Sharp Edge Labs recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sharp Edge Labs has new funding data
Sharp Edge Labs, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sharp Edge Labs is spiking on competitors!
Check if Sharp Edge Labs has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sharp Edge Labs launches new products
Recommended Actions
Find VP level buyers at Sharp Edge Labs
Find 2 more new buyers
Compare Similar Companies to Sharp Edge Labs
Compare insights from companies similar to Sharp Edge Labs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sharp Edge Labs is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sharp Edge Labs is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sharp Edge Labs.
Sharp Edge Labs Tech Stack
A closer look at the technologies used by Sharp Edge Labs
See more technologies
Sharp Edge Labs News & Media
Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board
PITTSBURGH and TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or the "Company") (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, announced today the appointment of Robin Ely, M.D., the Clinical Director and co-founder of the National Gaucher Foundation (NGF), to its Advisory Board.Sharp Therapeutics to Present Pipeline and Program Updates at World Orphan Drug Congress 2025
PITTSBURGH, Pa. and TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or the "Company") (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, today announced that it will present preclinical data from its lead Phase 1 ready ‘901 program being developed to treat Gaucher disease and Glucocerebrosidase (GBA) Parkinson's disease at the World Orphan Drug Congress 2025. The meeting will take place from October 27 t
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sharp Edge Labs
Sign Up For FreeTo access detailed company insights
Sharp Therapeutics is focused on developing first-choice medicines for hereditary disorders by utilizing high-speed experimentation and modern computational methods. Their innovative Disco platform enables the rapid discovery of small molecules aimed at correcting protein defects in conditions such as Gaucher Disease, Familial Frontotemporal Dement... Read More
